View / Download pdf version of this article
Brand changes for cardiovascular medicines: carvedilol, ezetimibe and ezetimibe with simvastatin
Over the next few months there will be changes in the subsidised brand of three cardiovascular medicines. The first
medicine to undergo a brand change was carvedilol on 1 April, 2015, which will be followed by ezetimibe and ezetimibe
with simvastatin from 1 June, 2015.
The same Special Authority restrictions for access to ezetimibe and ezetimibe with simvastatin will apply after the
For further information, see:
Patient information can be downloaded and printed from the website or ordered from:
If you have any enquiries about these changes, please phone 0800 60 00 50 between 9am–5pm, Monday to Friday.
Special Authority forms are available from: